RoukenBio, the collaborative research organization (CRO) formerly known as Antibody Analytics, has completed the phase 2 expansion of its Discovery Centre in Motherwell, Scotland, and unveiled its new brand identity.   An increase in demand for its preclinical immuno-oncology drug discovery services and cell-based bioassays coupled with growing market interest in auto-immunity, inflammation and allergic diseases has driven the need for the phase 2 expansion. It will enable the CRO to enhance i...